Tomoko Ichihara

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects

Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama et al. · Drug Research · 2017 · 40 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14

Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G1 phase of the cell cycle

Kazuya Fukuoka, Takehiro Yamagishi, Tomoko Ichihara et al. · International Journal of Cancer · 2000 · 31 citations · Full text

Medicine, Oncology, Pharmacology +13

In vivo activity on murine tumors of a novel antitumor compound, N-?-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)

Shiro Nakaike, Takehiro Yamagishi, Kazunori Samata et al. · Cancer Chemotherapy and Pharmacology · 1989 · 15 citations

Medicine, Medicinal Chemistry, Pharmacology +4

Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Yuka Aoyama, Toshiyuki Yamamoto, Naomi Sakaguchi et al. · International Journal of Molecular Medicine · 2015 · 14 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17